Precision Health,
Executed.

MENA's first dynamic biological performance OS — built in the UAE.
DNA · Blood Biomarkers · Microbiome · Wearables · Nutrition Execution
Founders
Mustafa Maghraby · Mariam Hourani
Stage
Live · 80+ customers · 8 partnerships
For
Hub71 · Apr 2026
01 / 11
The 60-Second Pitch

From the founders behind a UAE strategic exit (DUBZ → Emirates Group) and RawKure, a 7-year UAE-born premium functional-nutrition brand — Neotrium is building the region's first precision-health execution platform.

We connect DNA, blood biomarkers, microbiome insights and wearable data to personalised nutrition protocols — then execute them through DNA-matched meal plans that adapt as the client's biology changes.

Healthcare gives insight. Meal plans give food. Neotrium turns biological data into daily, measurable action.

Health is integrated. Healthcare is segregated. We bridge the gap.

Pitch
02 / 11
Why Abu Dhabi · Why Now

Three national priorities are converging. Neotrium sits at the intersection.

Abu Dhabi is investing heavily in preventive health, AI-native infrastructure, and precision healthcare. Neotrium translates those priorities into a scalable, outcome-driven nutrition platform.

01 · Preventive Health & Longevity

UAE Vision 2031 & the National Wellbeing Strategy

Prevention, quality of life, and healthy lifestyles are explicit national goals under We the UAE 2031. The infrastructure exists; the personalised execution layer does not. Neotrium converts diagnostics, biomarkers and lifestyle data into nutrition protocols that can be executed, tracked and improved.

UAE Vision 2031 · National Wellbeing Strategy
02 · AI-Native Government & Applied AI

World's first AI-native government by 2027

Abu Dhabi's stated ambition is to become the world's first AI-native government by 2027, supported by the 2025–2027 Digital Strategy. Hub71+ AI backs applied-AI use cases — Neotrium is exactly that: a knowledge engine translating multi-source biological data into structured, personalised nutrition execution.

Abu Dhabi Government Digital Strategy · Hub71+ AI
03 · Healthcare & Precision Medicine

Abu Dhabi's healthcare and genomics ecosystem

M42, PureHealth, Cleveland Clinic Abu Dhabi and Mubadala-backed assets have built deep capability in healthcare, genomics and AI-enabled health. What's missing is the layer between data and daily behaviour. That layer is Neotrium — precision health executed through nutrition.

M42 · PureHealth · Cleveland Clinic AD · Mubadala
Why AD
03 / 11
Meet the Team

Two founders. One operating system. Clinical depth behind it.

Why we built Neotrium

Neotrium was built from lived experience. Both founders come from families impacted by cancer, autoimmune disease, and chronic health conditions — and saw the same gap repeatedly: healthcare could identify the problem, but no structured system translated that insight into daily action. Health is integrated. Healthcare is segregated. Neotrium was built to bridge that gap.

Mustafa Maghraby

Mustafa Maghraby

Co-Founder & Chief Systems Architect
Founder of DUBZ, a UAE-born technology and operations company acquired by Emirates Group. At Neotrium, leads the systems architecture behind NEO-OS — knowledge base, prioritisation logic, dashboards, and the operational infrastructure that translates biological inputs into executable protocols.
Mariam Hourani

Mariam Hourani

Co-Founder & Precision Nutrition Architect
Founder of RawKure, a UAE-born premium functional-nutrition brand. Stanford-certified in Nutrition Science. Leads Neotrium's nutrition intelligence — 8 biological nutrition protocols and the 40+ biological-parameter recipe-tagging system mapping food to inflammation, insulin, gut, hormones, recovery and performance.
Clinical Advisory Board · 5 specialists across functional medicine, dietetics, nutrigenomics, women's health, performance
Sumaia Alkhub
Sumaia Alkhub
Functional & Regenerative Medicine
Zeina Maktabi
Zeina Maktabi · RD
Clinical Dietetics
Dr Tasnim El Gendy
Dr Tasnim El Gendy
Fertility & Women's Health
Joanne Ghanem
Joanne Ghanem
Nutrigenomics
Dr Milad Mansoori
Dr Milad Mansoori
Performance & Metabolic Health
Team
04 / 11
NEO-OS · The Intelligence Layer

Specialist-verified clinical AI. Built to make precision nutrition executable.

NEO-OS converts complex biological inputs — DNA, biomarkers, microbiome, wearables, CGM trends and client feedback — into structured, personalised nutrition protocols that can be executed, tracked and adapted over time.

Live Product · NEO-OS
NEO-OS app — DNA-matched meal recommendations with CGM trend and least-recommended foods
NEO Score · gene + sleep insight · compliance scorecards.
★ Knowledge Base · Brain

Specialist-encoded clinical rules

Specialists translate clinical and nutrition protocols into machine-readable rules. IF methylation support · THEN methyl-folate pathways. 40+ biological parameters mapping food to inflammation, insulin, gut, hormones, recovery and performance.

★ Prioritisation · Decision

Rule: Dynamic > Static

Real-time data overrides genetic baselines. IF Warrior Gene AND High Stress · THEN Adrenal Recovery. The system reasons across DNA, biomarkers, wearables continuously.

★ Weekly Adaptation · Execution Loop

The plan changes as the client changes

Every week, NEO-OS regenerates the meal plan against updated biomarkers, wearables, CGM, compliance and specialist edits. Data → Protocol → Meal Plan → Execution → Feedback.

★ Human-in-the-Loop · Learning

Every edit becomes a permanent rule

Specialist amends — "swap salmon, histamine sensitivity" → IF DAO variant · THEN remove histamine foods. Logged. Permanent. Growing intelligence.

80% of NEO-OS built · final product sprint underway · clinical advisory bench validates every rule. Built in MENA. Licensable across the GCC.
AI Engine
05 / 11
Live Traction · Apr 2026

We didn't build a deck. We built a business.

Revenue YTD
AED /200K
Three channels live · zero paid marketing · 4 months of operation.
Monthly Run-Rate
AED /50K
~AED 40–45K MRR · subscription-led · growing organically.
Active Customers
80+
~30 active in last 30 days · 100 people served including family extensions.
Multi-Month Retention
47%
Of customers who complete the initial program, 47% convert to recurring monthly meal plans.
✓
Licensed PartnersDHA / DOH-certified lab network · clinical practitioners onboarded & active.
↗
8 Partnerships in 60 DaysAll inbound · zero outbound prospecting. Distribution channels signed and live.
✓
Asset-Light FulfilmentContracted dark-kitchen partner cooking against our recipe-tag IP. No capex.
!
App in Final Sprint80% of platform built · final 20% to remove manual ops · production this quarter.
Traction
06 / 11
Strategic Ecosystem · Eight Partnerships in 60 Days

We're not selling to the market — the ecosystem is calling.

★ Mubadala-Adjacent · The signal that matters most

M42 — Mubadala × G42 healthcare JV

Mutual NDA active. Strategic conversation open with Abu Dhabi's anchor healthcare platform. M42 is built around precision medicine and AI-driven diagnostics — Neotrium is the precision-execution layer that closes the loop between their data infrastructure and daily patient behaviour.

For Hub71 leadership: this is dialogue inside the parent ecosystem.
Signed / Live
Valeo
Largest funded MENA longevity platform. Mutual referral signed.
VEO × Emaar
White-label across 4 Dubai properties. Finalising.
Almond Blossom Fertility
Live patient referrals · 2 active.
MENOVIVRE
Dr. Tasnim · live clinical channel.
Meal Planet
B2B aggregator · 430 orders Q1.
Clinical Bench
5 specialists signed.
In Dialogue / Inbound
Agiomx Group · Precision Wellness
Regenerative-medicine and precision-wellness platform · inbound this week.
Omics Longevity
Referral partnership agreed.
All inbound — none of these were outbound prospecting. Distribution channels, not pipeline.
Ecosystem
07 / 11
Hub71 Fit · Dual-Track

The SaaS Layer. Built for both Hub71+ tracks.

Neotrium is what we license to GCC clinics from Year 3. The same platform sits naturally inside both Hub71+ Life Sciences and Hub71+ AI — and the intersection is where Abu Dhabi's strategic agenda actually lives.

★ The SaaS Product · Clinic Dashboard
NEO-OS clinic dashboard — client roster, critical actions, biological age clocks
What we license to GCC clinics from Year 3 · 85% gross margin
Hub71+ Life Sciences

Precision medicine, operationalised.

  • → DOH / DHA-licensed clinical pathway live
  • → 5-clinician advisory bench · every protocol verified
  • → M42 dialogue active — Mubadala-adjacent
Hub71+ AI

Applied AI in regulated healthcare.

  • → 40+ biological-parameter rule engine · proprietary IP
  • → Specialist-in-the-loop · every edit logs a permanent rule
  • → Y3: most valuable genomic-nutrition dataset in GCC
Keyword matches: precision medicine (Life Sciences) · applied AI in regulated industries (AI). One platform. Two strategic fits.
Hub71 Fit
08 / 11
Updated 5-Year Model · vVC · 50% Conversion

From concierge to platform — USD 0.7M → 20M.

Revenue · USD M

Updated FM · 50% one-time → meal-plan conversion
0 5 10 15 FY1 FY2 FY3 FY4 FY5 0.69 1.76 4.63 8.98 16.05

EBITDA & Cumulative Cash · USD M

Operating profitability hits in FY3 · cash positive Q4
8 4 0 -2 FY1 FY2 FY3 FY4 FY5 EBITDA+
EBITDA Cumulative Cash
USD M FY1 FY2 FY3 FY4 FY5
Revenue 0.69 1.76 4.63 8.98 16.05
Gross Margin 27% 24% 74% 80% 82%
EBITDA (0.26) (0.53) 0.94 2.98 6.32
Cumulative Cash (0.53) (1.12) (0.39) 2.05 7.32
Base case: $16M FY5. $20M ambition with accelerated KSA entry & clinic ramp. FY2 EBITDA reflects deliberate capex into NEO-OS & kitchen scaling. FY3 inflection · 82% SaaS gross margin by FY5
Trajectory
09 / 11
Let's Build From Abu Dhabi

Precision health needs an execution layer. Neotrium is building it.

We're not approaching Hub71 simply for capital. We're looking for the right ecosystem to scale Neotrium from Abu Dhabi into the GCC. Hub71 is the natural home for what we're building: a UAE-born precision-health platform at the intersection of AI, life sciences, clinical nutrition and scalable health infrastructure.

What we're looking for
01
Strategic Hub71 Alignment

A working session with the relevant Life Sciences, HealthTech, and AI leads to validate our dual-track thesis and map the strongest path into the Hub71 ecosystem.

02
Targeted Ecosystem Introductions

(i) M42 — to explore pilot scope around precision-health execution. (ii) PureHealth — clinic licensing and health-system integration. (iii) DOH / ADHA — regulatory pathway for clinical SaaS and nutrition execution.

03
Pathway Into Hub71

A clear route into the most relevant Hub71 program or cohort, with Abu Dhabi as Neotrium's regional base for product, partnerships, and GCC expansion.

What we commit to
A flagship Life Sciences × AI × Nutrition case
  • Live, revenue-generating precision-health platform — built in MENA
  • Two-founder team: a UAE strategic exit (Mustafa · DUBZ → Emirates) and a UAE-born premium nutrition brand (Mariam · RawKure)
  • 5-clinician advisory bench · DHA / DOH-licensed pathway
  • Active dialogue with M42 — Mubadala-adjacent
Concrete commitments
  • Establish Abu Dhabi as Neotrium's regional HQ · ADGM domicile
  • Hire AI, clinical, and healthtech talent locally
  • Make Abu Dhabi the licensing hub for clinic and wellness partnerships
Mustafa Maghraby · mustafa@neotrium.com · neotrium.com Built in the UAE. Ready to scale from Abu Dhabi.
Let's Build
10 / 11
The Round · USD 1M Seed · SAFE

USD 1M. 24 months. Series A on our terms.

Live revenue · two founders with regional exits · 8 paying clients · AED 200K YTD with zero paid marketing. We're raising USD 1M to scale to 5 GCC clinic partners and KSA pre-launch — then Series A.

★ Round Structure
Raising USD 1M Instrument SAFE Pre-money cap USD 8M Post-money USD 9M Equity offered 11.1% Min ticket USD 100K Target ticket USD 150–200K Lead investor Preferred terms available Runway 24 months
Capital deployment · USD 1M
  • 40% · 400K Tech & NEO-OS — Knowledge Base, Prioritisation Engine, clinic dashboard
  • 30% · 300K Kitchen & supply chain — securing unit economics, scaling capacity
  • 30% · 300K Operations & key hires — AI, clinical, healthtech team in AD
Outcomes & milestones
  • → Operations cash-positive by Month 8 (25 clients · unit-economic)
  • → 5 GCC clinic partners onboarded by Month 18
  • → KSA pre-launch by Month 20
  • → EBITDA-positive by FY3 · 82% SaaS gross margin by FY5
FY1–FY2 EBITDA reflects deliberate deployment of seed capital into NEO-OS build and kitchen scaling. Operations remain unit-economic positive throughout — cash-positive ops, capex-driven P&L burn.
Mustafa Maghraby · mustafa@neotrium.com · neotrium.com · ADGM domicile USD 1M · SAFE · 24-month runway
The Round
11 / 11
📱

Best viewed in landscape

This deck is built at slide proportions. Rotate your phone for full-size slides — or continue in portrait.